摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(二乙基氨基)乙基苯乙烯 | 74952-73-1

中文名称
2-(二乙基氨基)乙基苯乙烯
中文别名
——
英文名称
N,N-Diethyl-4-phenylbut-3-en-1-amine
英文别名
——
2-(二乙基氨基)乙基苯乙烯化学式
CAS
74952-73-1
化学式
C14H21N
mdl
——
分子量
203.32
InChiKey
UQADNXUWLBEGLY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    15
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    3.2
  • 氢给体数:
    0
  • 氢受体数:
    1

文献信息

  • [EN] NUCLEIC ACID COMPLEX<br/>[FR] COMPLEXE D'ACIDE NUCLÉIQUE
    申请人:COMMW SCIENT IND RES ORG
    公开号:WO2013003887A1
    公开(公告)日:2013-01-10
    The present invention relates to a complex comprising a cationic block copolymer and a nucleic acid, the cationic block copolymer having at least a tri-block structure comprising a cationic block and two hydrophilic blocks, or a hydrophilic block and two cationic blocks.
    本发明涉及一种包含阳离子嵌段共聚物和核酸的复合物,其中所述阳离子嵌段共聚物至少具有三嵌段结构,包括一个阳离子嵌段和两个亲性嵌段,或一个亲性嵌段和两个阳离子嵌段。
  • Modifier, modified and conjugated diene-based polymer and methods for preparing them
    申请人:LG Chem, Ltd.
    公开号:US10450387B2
    公开(公告)日:2019-10-22
    The present invention relates to a modifier and a modified and conjugated diene-based polymer including a functional group derived therefrom, and more particularly, provides a modifier including a compound represented by Formula 1, a modified and conjugated diene-based polymer including a functional group derived from the modifier and a repeating unit derived from a conjugated diene-based monomer, and methods for preparing them. In Formula 1, the definition of each substituent is the same as defined in the description of the invention.
    本发明涉及一种改性剂和一种改性和共轭二烯基聚合物,其中包括由此衍生的功能基团,更具体地提供了一种包括由化合物表示的 Formula 1 所代表的改性剂,一种包括从改性剂衍生的功能基团和从共轭二烯基单体衍生的重复单元的改性和共轭二烯基聚合物,以及它们的制备方法。在 Formula 1 中,每个取代基的定义与发明说明中定义的相同。
  • Cosmetic and/or pharmaceutical composition comprising at least one copolymer comprising at least one ionizable group, and cosmetic treatment process
    申请人:Mougin Nathalie
    公开号:US20070264208A1
    公开(公告)日:2007-11-15
    Disclosed herein is a cosmetic and/or pharmaceutical composition comprising, in a physiologically acceptable medium, at least one (co)polymer comprising a polymer backbone and at least one junction group linked to the polymer backbone and capable of establishing H bonds with at least one partner junction group, each pairing of a junction group involving at least 3 H bonds, wherein the at least one (co)polymer comprises at least one ionizable group. Also disclosed herein is a cosmetic treatment process comprising applying the composition to keratin materials.
    本文揭示了一种化妆品和/或药用组合物,包括在生理可接受的介质中,至少包含一种(共)聚合物,该聚合物包括聚合物骨架和至少一个连接到聚合物骨架并能够与至少一个配对连接基团建立H键的交联基团,每个连接基团的配对涉及至少3个H键,其中至少一种(共)聚合物包括至少一个可离子化基团。本文还揭示了一种化妆处理过程,包括将该组合物应用于角蛋白材料。
  • COSMETIC TREATMENT PROCESSES AND KIT
    申请人:Dublanchet Anne-Claude
    公开号:US20140155352A1
    公开(公告)日:2014-06-05
    The present invention relates to a cosmetic process for treating keratin materials, which can give them, especially in a long-lasting and reversible manner, interesting cosmetic properties; this process comprising the application to said materials: in a first stage, of a cosmetic composition comprising at least one graftable species, comprising at least one unit of formula (Ia): and in a second stage, of a cosmetic composition comprising at least one cosmetic active agent bearing at least one unit of formula (Ia): The invention also relates to a kit comprising said compositions.
    本发明涉及一种用于处理角蛋白材料的化妆品工艺,可以在长期和可逆的情况下赋予它们有趣的化妆品特性;该工艺包括向所述材料施加以下组成部分的应用:第一阶段,包括至少一种可接枝的物种的化妆品组合物,其中包括至少一个式(Ia)的单元;第二阶段,包括至少一种具有至少一个式(Ia)的化妆品活性剂的化妆品组合物:本发明还涉及包括所述组合物的套件。
  • Cosmetic composition containing a statistical polymer with a linear main chain of ethylenic nature
    申请人:Schultze Xavier
    公开号:US20070092473A1
    公开(公告)日:2007-04-26
    A cosmetic composition includes, in a physiologically acceptable medium, at least one statistical copolymer with a linear main chain of ethylenic nature, in which the copolymer: (i) has a weight-average molecular mass of between 15,000 and 600,000 g/mol, and has: (a) at least 70% by weight of “monomer units” derived from monomers for which the homopolymers are hydrophobic and have a glass transition temperature of greater than 40° C., (b) at least one “monomer unit” derived from an at least partially neutralized ionic hydrophilic monomer, (c) 0 to 25% by weight of “monomer units” derived from additional monomers for which the homopolymers have a glass transition temperature of less than 40° C., chosen from: the acrylates of formula: CH 2 ═CHCOOR 12 in which R 12 represents a linear or branched C 1 to C 12 alkyl group with the exception of a tert-butyl group, in which is (are) optionally intercalated one or more identical or different heteroatoms, the alkyl group also possibly being optionally substituted with one or more identical or different substituents chosen from hydroxyl groups and halogen atoms, and the methacrylates of formula: CH 2 ═C(CH 3 )COOR 14 in which R 14 represents a linear C 4 to C 12 alkyl group or a branched C 5 to C 12 alkyl group, and (ii) has an overall glass transition temperature of greater than or equal to 45° C.
    一种化妆品组合物,包括在生理上可接受的介质中,至少含有一种具有乙烯基性线性主链的统计共聚物,其中该共聚物:(i)具有15,000至600,000克/摩尔的重均分子量,并具有:(a)至少70%的重量来自于单体,其均聚物是亲性的且具有大于40°C的玻璃转移温度,(b)至少一种来自于至少部分中和的离子亲性单体的“单体单元”,(c) 0至25%的重量来自于附加单体的“单体单元”,其均聚物的玻璃转移温度小于40°C,所选单体为:公式为CH2═CHCOOR12的丙烯酸酯,其中R12表示线性或支链C1到C12烷基,除了叔丁基基团外,在其中可选地插入一个或多个相同或不同的杂原子,该烷基还可能被一个或多个相同或不同的取代基取代,所述取代基选择自羟基和卤素原子,以及公式为 ═C(CH3)COOR14的甲基丙烯酸酯,其中R14表示线性C4到C12烷基或支链C5到C12烷基,(ii)具有大于或等于45°C的总玻璃转移温度。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫